AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 74(5), 2006, pp. 744-749
Copyright © 2006 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WELLS, T. S.
Right arrow Articles by RYAN, M. A.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WELLS, T. S.
Right arrow Articles by RYAN, M. A.K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Malaria
*Mental Health
Hazardous Substances DB
*MEFLOQUINE
Related Collections
Right arrow Malaria

MEFLOQUINE USE AND HOSPITALIZATIONS AMONG US SERVICE MEMBERS, 2002–2004

TIMOTHY S. WELLS, TYLER C. SMITH, BESA SMITH, LINDA Z. WANG, CHRISTIAN J. HANSEN, ROBERT J. REED, WENDY E. GOLDFINGER, THOMAS E. CORBEIL, CHRISTINA N. SPOONER, AND MARGARET A.K. RYAN*
Department of Defense Center for Deployment Health Research, Naval Health Research Center, San Diego, California

The safety of mefloquine has not been well described in military populations. This study used standard military databases for mefloquine prescriptions and hospitalizations to investigate mefloquine safety among US service members from 2002 through 2004. Mefloquine-prescribed and deployed personnel (N = 8,858) were compared with two reference groups. The reference groups comprised US service members who were not prescribed mefloquine and resided in Europe or Japan (N = 156,203) or had been otherwise deployed (N = 232,381). In comparison with active-duty US service members residing in Europe or Japan, mefloquine-prescribed service members were at statistically significant decreased hazard for any-cause hospitalization, as well as diseases of the respiratory and digestive systems, musculoskeletal system and connective tissue diseases, injuries and poisonings, ill-defined conditions, and mood disorders. These results suggest there is no association between mefloquine prescriptions and severe health effects, as measured by hospitalizations, across a wide range of outcomes.

Received September 8, 2005. Accepted for publication December 27, 2005.

Acknowledgments: The authors thank Dr. M. David Rudd, Baylor University, for assistance in the design of this study, Scott Seggerman and his team of professionals at the Defense Manpower Data Center, for providing the necessary demographic data; Dr. David Guerin and his team of professionals for providing access to the Military Health Systems Management Analysis and Reporting Tool for both pharmacy data and hospitalization data; and Dr. Roger Gibson and the Armed Forces Epidemiological Board and Dr. Steven Phillips, Director, Deployment Medicine and Surveillance, Office of the Assistant Secretary of Defense, Health Affairs, for providing expertise in study design and for critical review of the manuscript. Dr. Wells had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

This represents report 05–05, supported by the Department of Defense, under work unit no. 60002. The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, or the US Government. Approved for public release; distribution is unlimited.

* Address correspondence to Margaret A. K. Ryan, DoD Center for Deployment Health Research, PO Box 85122, Naval Health Research Center, San Diego, CA 92186-5122. E-mail: ryan{at}nhrc.navy.mil

Authors’ addresses: Timothy S. Wells, Building 824, Room 206, 2800 Q Street, Wright-Patterson AFB, OH, 45433, E-mail: timothy.wells{at}wpafb.af.mil. Tyler C. Smith, Besa Smith, Linda Z. Wang, Christian J. Hansen, Robert J. Reed, Wendy E. Goldfinger, Thomas E. Corbeil, Christina N. Spooner, and Margaret A. K. Ryan, DoD Center for Deployment Health Research, PO Box 85122, Naval Health Research Center, San Diego, CA 92186-5122, E-mails: Smith{at}nhrc.navy.mil, Besa{at}nhrc.navy.mil, Wang{at}nhrc.navy.mil, Hansen{at}nhrc.navy.mil, Reed{at}nhrc.navy.mil, Wgoldfinger{at}hotmail.com, Tecorbeil{at}hotmail.com, Spooner{at}nhrc.navy.mil, and Ryan{at}nhrc.navy.mil.




This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
P. Schlagenhauf and E. Petersen
Malaria Chemoprophylaxis: Strategies for Risk Groups
Clin. Microbiol. Rev., July 1, 2008; 21(3): 466 - 472.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
L. H. Chen, M. E. Wilson, and P. Schlagenhauf
Controversies and Misconceptions in Malaria Chemoprophylaxis for Travelers
JAMA, May 23, 2007; 297(20): 2251 - 2263.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
L. H. Chen, M. E. Wilson, and P. Schlagenhauf
Prevention of malaria in long-term travelers.
JAMA, November 8, 2006; 296(18): 2234 - 2244.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society of Tropical Medicine and Hygiene.